Abstract:
PURPOSE: An implant surface treatment solution, a surface treatment method using the same, and an implant manufactured thereby are provided to facilitate the adhesion of bone. CONSTITUTION: An implant surface treatment method comprises an anode oxidation step. In the anode oxidation step, an anode is made of titanium or titanium alloy, a cathode is made of platinum, tungsten, or silver, and solution becomes electrolyte. In a cosntant voltage and current mode, the density of current is 5-50 mA/cm^2 and the final voltage is 10-40 volt and is maintained for five minutes to two hours in the final voltage condition.
Abstract translation:目的:提供植入物表面处理溶液,使用其的表面处理方法以及由其制造的植入物,以促进骨的粘附。 构成:植入物表面处理方法包括阳极氧化步骤。 在阳极氧化步骤中,阳极由钛或钛合金制成,阴极由铂,钨或银制成,溶液变成电解质。 在谐振电压和电流模式下,电流密度为5-50 mA / cm ^ 2,最终电压为10-40 V,在最终电压条件下保持5分钟至2小时。
Abstract:
본발명은마크로락틴 F 또는이의염을유효성분으로함유하는골질환의예방, 치료또는개선용조성물및 기능성식품에관한것으로, 구체적으로마크로락틴 F 또는이의염을유효성분으로함유하여파골세포의형성을억제하고조골세포의형성을촉진함으로써골질환을효과적으로예방, 치료또는개선할수 있는약제학적조성물, 의약외품조성물및 기능성식품에관한것이다. 본발명의약제학적조성물, 의약외품조성물및 기능성식품은마크로락틴 F 또는이의염을유효성분으로함유하여파골세포의형성을억제하고조골세포의형성을촉진할수 있다. 따라서과다한파골세포형성및 조골세포형성의감소로인한뼈 리모델링의불균형상태를복구할수 있으며, 이러한불균형상태로인해발생하는골질환을효과적으로예방, 치료또는개선할수 있다.
Abstract:
PURPOSE: A composition containing Coptis japonica(Thunb.) extract is provided to reduce damage of gingival bone and to treat periodontitis. CONSTITUTION: A method for manufacturing a composition for treating periodontitis comprises: a step of extracting 100g of Coptis japonica(Thunb.) extract with 800 ml of purified water at 80-100°C for three hours; a step of filtering the extract at 200 meshes; a step of compressing under 60°C for concentration; and a step of mixing the extract, vitamin C, and vitamin E. The composition is an oral or injection formulation. The oral formulation is a granule, tablet, capsule, and liquid.
Abstract:
PURPOSE: A titanium implant surface treatment method and an implant manufactured by the same are provided to promote the symphysis of bone. CONSTITUTION: A titanium implant surface treatment method comprises: a step of forming a titanium dioxide nanotube on the implant surface of titanium or titanium alloy by oxidizing anode by using an electrolyte solution; and a step of infiltrating a bisphosphonate drug solution and the mixture of bisphosphonate drug solution and antibiotic into the implant surface where a titanium dioxide nanotube is formed.